Adi Mor - Jan 3, 2023 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Role
Chief Scientific Officer, Director
Signature
/s/ David S. Glatt, Attorney-in-Fact for Adi Mor and Kobi George.
Stock symbol
CMMB
Transactions as of
Jan 3, 2023
Transactions value $
-$69,370
Form type
4
Date filed
1/5/2023, 03:01 PM
Previous filing
Nov 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMMB American Depositary Shares Sale -$38.7K -7.7K -2.37% $5.03 317K Jan 3, 2023 Direct F1, F2
transaction CMMB American Depositary Shares Sale -$30.7K -6.1K -2.37% $5.03 251K Jan 3, 2023 By Kobi George, the Reporting Person's spouse F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMMB Option to Purchase American Depositary Shares Award $0 +132K $0.00 132K Mar 15, 2018 American Depositary Shares 132K $1.49 Direct F1, F3, F4
transaction CMMB Option to Purchase American Depositary Shares Award $0 +33.7K $0.00 33.7K Oct 28, 2016 American Depositary Shares 33.7K $0.80 By Kobi George, the Reporting Person's spouse F1, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F2 This transaction was effected pursuant to a 10b5-1 plan entered into on September 19, 2022.
F3 No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F4 These options have vested and are exercisable as of the date hereof.
F5 These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.